{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:29:26Z","timestamp":1792024166378,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2897,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/sj.ki.5002653","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T16:23:33Z","timestamp":1194452613000},"page":"154-162","source":"Crossref","is-referenced-by-count":28,"title":["Mycophenolate mofetil in primary glomerulopathies"],"prefix":"10.1016","volume":"73","author":[{"given":"V.","family":"Sepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Libetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dal Canton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002653_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanism of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1038\/sj.ki.5002653_bb0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002653_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.berh.2005.05.005","article-title":"Diagnosis and treatment of kidney disease","volume":"19","author":"Cross","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2 Suppl","key":"10.1038\/sj.ki.5002653_bb0025","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1097\/01.tp.0000187035.22298.ba","article-title":"Review of major clinical trials with mycophenolate mofetil in renal transplantation","volume":"80","author":"Ciancio","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002653_bb0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00041552-199909000-00005","article-title":"Non-transplant uses of mycophenolate mofetil","volume":"8","author":"Jayne","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/sj.ki.5002653_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1191\/096120301673517315","article-title":"Treatment of systemic lupus erythematosus with mycophenolate mofetil","volume":"10","author":"Adu","year":"2001","journal-title":"Lupus"},{"key":"10.1038\/sj.ki.5002653_bb0040","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases","volume":"27","author":"Gelber","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1038\/sj.ki.5002653_bb0045","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(87)70285-0","article-title":"Mycophenolic acid for psoriasis. A review of pharmacology, long term efficacy and safety","volume":"17","author":"Epinette","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.ki.5002653_bb0050","first-page":"484","article-title":"Sperimentate su culture pure di bacilli del carbonchio dimonstrarono notevole potere antisettico","volume":"61","author":"Gosio","year":"1893","journal-title":"C R Acad Med Torino"},{"key":"10.1038\/sj.ki.5002653_bb0055","first-page":"7","article-title":"Contributions to the study of maize deterioration","volume":"270","author":"Alsberg","year":"1913","journal-title":"US Dept.of Agr. Bur. Plant Ind. Bull"},{"key":"10.1038\/sj.ki.5002653_bb0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1042\/bj0500630","article-title":"Studies in the biochemistry of micro-organisms 86. The molecular constitution of mycophenolic acid, a metabolic product of Penicillium Brevi-compactum Dierckx. Part III. Further observations on the structural formula for mycophenolic acid","volume":"50","author":"Birkinshaw","year":"1952","journal-title":"Biochem J"},{"key":"10.1038\/sj.ki.5002653_bb0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/bj1130515","article-title":"The inhibition of nucleic acid synthesis by mycophenolic acid","volume":"113","author":"Franklin","year":"1969","journal-title":"Biochem J"},{"key":"10.1038\/sj.ki.5002653_bb0070","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization of human type I and type II IMP dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002653_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","article-title":"Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil","volume":"136","author":"Allison","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1038\/sj.ki.5002653_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1074\/jbc.M507056200","article-title":"Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP","volume":"281","author":"Ji","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5002653_bb0085","first-page":"3205","article-title":"Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation","volume":"26","author":"Allison","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1038\/sj.ki.5002653_bb0090","series-title":"Effects of RS-5797-000 (mycophenolic acid) on the amounts of ATP and GTP in polymorphonuclear cells and in adherent and non-adherent human mononuclear cells","author":"Byars","year":"1993"},{"issue":"2 Suppl","key":"10.1038\/sj.ki.5002653_bb0095","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1097\/01.tp.0000186390.10150.66","article-title":"Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection","volume":"80","author":"Allison","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002653_bb0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/07853890600978149","article-title":"Molecular basis of the glomerular filtration: nephrin and the emerging complex at the podocyte slit diaphragm","volume":"38","author":"Patari-Sampo","year":"2006","journal-title":"Ann Med"},{"key":"10.1038\/sj.ki.5002653_bb0105","doi-asserted-by":"crossref","first-page":"F880","DOI":"10.1152\/ajprenal.00451.2004","article-title":"Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies","volume":"289","author":"Nakhoul","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5002653_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000092948","article-title":"Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat","volume":"29","author":"Bloudickova","year":"2006","journal-title":"Kidney Blood Press Res"},{"key":"10.1038\/sj.ki.5002653_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/14.1.58","article-title":"Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion","volume":"14","author":"Hauser","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002653_bb0120","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2005.00496.x","article-title":"Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat","volume":"68","author":"Rodriguez-Iturbe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002653_bb0125","doi-asserted-by":"crossref","first-page":"F359","DOI":"10.1152\/ajprenal.00442.2004","article-title":"Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril","volume":"289","author":"Kramer","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5002653_bb0130","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.transproceed.2004.07.057","article-title":"Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1038\/sj.ki.5002653_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US renal transplant Mycophenolate Mofetil study group","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002653_bb0140","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","author":"Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","year":"1996","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002653_bb0145","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00007890-199603150-00009","article-title":"Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection","volume":"61","author":"Mycophenolate Mofetil Renal Refractory Study Group","year":"1996","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5002653_bb0150","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/ndt\/gfg1027","article-title":"Renal function as a predictor of long-term graft survival in renal transplant patients","volume":"18","author":"First","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002653_bb0155","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","article-title":"Sequential therapies for proliferative lupus nephritis","volume":"350","author":"Contreras","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002653_bb0160","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002653_bb0165","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/kei019","article-title":"Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy","volume":"44","author":"Karim","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1038\/sj.ki.5002653_bb0170","first-page":"1047","article-title":"Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients","volume":"32","author":"Pisoni","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1038\/sj.ki.5002653_bb0175","first-page":"289","article-title":"Report of the Canadian hypertension society consensus conference: 1. Introduction","volume":"149","author":"Carruthers","year":"1993","journal-title":"CMAJ"},{"key":"10.1038\/sj.ki.5002653_bb0180","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00467-005-1877-x","article-title":"Mycophenolate mofetil in steroid\/cyclosporine-dependent\/resistant nephrotic syndrome","volume":"20","author":"Mendiz\u00e1bal","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002653_bb0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","article-title":"Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil","volume":"19","author":"Gellermann","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002653_bb0190","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/ndt\/17.11.2011","article-title":"Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome","volume":"17","author":"Day","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002653_bb0195","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular diseases","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002653_bb0200","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5414\/CNP62405","article-title":"Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis","volume":"6","author":"Cattran","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5002653_bb0205","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00467-003-1174-5","article-title":"Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade","volume":"18","author":"Montan\u00e9","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002653_bb0210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/ajkd.2000.8968","article-title":"Use of mycophenolate mofetil in resistant membranous nephropathy","volume":"36","author":"Miller","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002653_bb0215","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ndt\/gfg113","article-title":"Mycophenolate mofetil treatment of idiopathic stages III\u2013IV membranous nephropathy","volume":"18","author":"Polenakovic","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002653_bb0220","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","article-title":"Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study","volume":"65","author":"Maes","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002653_bb0225","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/ndt\/gfh974","article-title":"Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized trial","volume":"20","author":"Frisch","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002653_bb0230","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1523-1755.2005.00460.x","article-title":"Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815529591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815529591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:44:54Z","timestamp":1630025094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815529591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0085253815529591"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002653","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}